Topiramate
Product Images NDC 53217-291

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 53217-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Topiramate Usp 25mg 1)

FDA Label Image

Topi (Topiramate Usp 25mg 2)

Topi (Topiramate Usp 25mg 2)
The text describes a chart or graph that shows cumulative rates for time intervals. The chart has an x-axis that ranges from 0 to 450 with increments of 50. The y-axis ranges from 0 to 0.3 with increments of 0.1. There is a marked point on the chart at 0.2 with a label underneath that says "010 p =0.0002". The context of what the chart is actually referencing is not available.*
FDA Label Image

Image Description (Topiramate Usp 25mg 3)

Image Description (Topiramate Usp 25mg 3)
This is a description of a medication called Topiramate, USP. The medication comes in a round, white, film-coated tablet in 25mg and 50mg doses. It is sold in bottles of 60 tablets each and is used to treat epilepsy and migraines. The drug manufacturer is Gipla Ltd. based in India. Lot and NDC numbers are also included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.